Dual roles of PARP-1 promote cancer growth and progression.
about
Safe handling of oral antineoplastic medications: focus on targeted therapeutics in the home settingTherapeutic Implications for Overcoming Radiation Resistance in Cancer TherapyChromatin Dynamics in Vivo: A Game of Musical ChairsBeyond DNA repair: DNA-PK function in cancerDNA damage response and prostate cancer: defects, regulation and therapeutic implicationsBiologic and clinical significance of androgen receptor variants in castration resistant prostate cancerThe convergence of DNA damage checkpoint pathways and androgen receptor signaling in prostate cancerTargeting the adaptive molecular landscape of castration-resistant prostate cancerDNA damage response genes and the development of cancer metastasisTargeting DNA repair with combination veliparib (ABT-888) and temozolomide in patients with metastatic castration-resistant prostate cancerAndrogen synthesis inhibitors in the treatment of castration-resistant prostate cancer.Poly (ADP-ribose) polymerase inhibitor: an evolving paradigm in the treatment of prostate cancer.Genomic profile of human meningioma cell lines.Combination Platinum-based and DNA Damage Response-targeting Cancer Therapy: Evolution and Future Directions.Targeting poly(ADP-ribose) polymerase and the c-Myb-regulated DNA damage response pathway in castration-resistant prostate cancer.Basal activity of a PARP1-NuA4 complex varies dramatically across cancer cell lines.Molecular pathways and targets in prostate cancerPARP-1 regulates epithelial-mesenchymal transition (EMT) in prostate tumorigenesisEPI-001 is a selective peroxisome proliferator-activated receptor-gamma modulator with inhibitory effects on androgen receptor expression and activity in prostate cancerConsequence of the tumor-associated conversion to cyclin D1bThe Rheumatoid Arthritis Risk Variant CCR6DNP Regulates CCR6 via PARP-1.PARP1 Inhibitors: antitumor drug design.Active FOXO1 Is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming.Linking DNA Damage and Hormone Signaling Pathways in Cancer.Mitotic bookmarking: maintaining post-mitotic reprogramming of transcription reactivationOf Mice and Melanoma: PDX System for Modeling Personalized Medicine.Differential Effects of Estradiol and Bisphenol A on SET8 and SIRT1 Expression in Ovarian Cancer Cells.A-ring oxygenation modulates the chemistry and bioactivity of caged Garcinia xanthones.Post-transcriptional regulation by poly(ADP-ribosyl)ation of the RNA-binding proteins.Differential regulation of cell death programs in males and females by Poly (ADP-Ribose) Polymerase-1 and 17β estradiolPKCα and HMGB1 antagonistically control hydrogen peroxide-induced poly-ADP-ribose formation.Targeted radiosensitization of ETS fusion-positive prostate cancer through PARP1 inhibition.A hormone-DNA repair circuit governs the response to genotoxic insultBeyond DNA Repair: Additional Functions of PARP-1 in Cancer.Small interfering RNA-mediated silencing of nicotinamide phosphoribosyltransferase (NAMPT) and lysosomal trafficking regulator (LYST) induce growth inhibition and apoptosis in human multiple myeloma cells: A preliminary study.The Correlation Between PARP1 and BRCA1 in AR Positive Triple-negative Breast Cancer.Targeting PARP-1 allosteric regulation offers therapeutic potential against cancer.Molecular pathways: targeting resistance in the androgen receptor for therapeutic benefitTargeting DNA Repair in Cancer: Beyond PARP Inhibitors.PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes.
P2860
Q23923997-7B4C0017-5FCF-437C-B002-71713F053128Q26777016-D25A526D-1377-4F7D-BEC4-2319EA547B67Q26799305-E93176F0-4D6B-467F-95BD-5FE8B134BB08Q26827232-8718E50D-B75A-430E-B315-6CCC61FDC916Q26829155-B806F214-A072-46D6-B991-FD7E02FA7AACQ26858922-822B281B-729D-4804-92AF-A987B9071E54Q27014101-5A88587D-6510-4917-8DC0-AB57F4CD4DEFQ27022821-3021187B-0D91-4591-89E6-24F8099FA66DQ28388312-308490D3-45FF-4880-968C-88D2648F1063Q33414863-692380B4-D83D-4841-811E-D52A80E41DD8Q33621403-A07EBE7E-16A7-4C5B-B125-AA26CA954523Q33621410-127125EC-73CB-4518-A9C8-DBA50F6E44DFQ33731952-B066D041-C88C-442E-8129-6E50727BE8C7Q33798999-DFB915DF-87FD-46A5-B992-3A395718952AQ34055827-5972B838-EED9-4241-9B39-7E029B3C6565Q34254927-F7331BEA-F21D-4DB8-BEA8-564F3D26870DQ34365632-B803A24E-B828-4916-B945-BCDEC5198601Q34434937-4A4AAEFB-36AA-4BC6-83CE-04C6ECE82A52Q34462138-4929CFF0-75F6-42D6-84D1-32040729E4B4Q35822584-3CE6F418-2B19-4765-B8B0-5225FEFBD023Q36132464-33282AC1-7FE8-4896-A56E-296658A27981Q36175159-6DDBD76F-9154-4F18-B9A2-8DB17B8AEF24Q36586384-5FD2795B-00E4-4584-A896-531E19659BAFQ36730819-0E8CA329-2588-4C54-8D39-4CFF6BFAC94EQ36745362-2165DA5D-D6E8-493E-828E-00D1F7D64A89Q36759429-85A67D1B-C29B-485F-901B-383C6D25B014Q36796436-1DB92989-3403-4A56-A0A5-C2DBB0D66F0FQ36846377-1F1E7C83-83A7-4452-AA9E-C15D70CEED6DQ37139138-87D9871C-648A-43AD-9D75-5CBDB2D8BC1BQ37148205-14030092-6F03-4087-9D55-E5C49B3868AEQ37264322-A2702AAC-3F9F-4B71-9500-D606D5322987Q37285569-BD642F9D-E8E1-42AB-B844-70A0ABDFE744Q37297350-0C4CA8D6-861D-4ADC-A658-022856378352Q37346306-7B9A7D96-58BB-44C6-839C-4C25BBA15CAFQ37471806-75C4F307-3B23-4DB5-BF29-4B1E44073751Q37513919-F50A3E47-30D0-4390-BC1C-10749283FBD3Q37521242-0D469846-5906-4AE5-AEB0-473FEC61FDD4Q37620953-14DDF60F-9C01-4866-BF4F-A4E7E5E05CF1Q37634102-78692B3F-C628-4A9F-959D-171A2F2EE0D0Q37661664-A8DEBCCA-09C4-4874-83EA-B99BA8C23B9B
P2860
Dual roles of PARP-1 promote cancer growth and progression.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Dual roles of PARP-1 promote cancer growth and progression.
@ast
Dual roles of PARP-1 promote cancer growth and progression.
@en
type
label
Dual roles of PARP-1 promote cancer growth and progression.
@ast
Dual roles of PARP-1 promote cancer growth and progression.
@en
prefLabel
Dual roles of PARP-1 promote cancer growth and progression.
@ast
Dual roles of PARP-1 promote cancer growth and progression.
@en
P2093
P2860
P50
P1433
P1476
Dual roles of PARP-1 promote cancer growth and progression.
@en
P2093
Arul M Chinnaiyan
Felix Y Feng
Fengzhi Liu
Ganesh V Raj
J Chad Brenner
Jamie L Planck
Jeffry L Dean
John M Pascal
Jonathan F Goodwin
Jonathan R Brody
P2860
P304
P356
10.1158/2159-8290.CD-12-0120
P577
2012-09-19T00:00:00Z